RPC, Inc. RES
5.60 USD 0.00 (+0.00%)
At closeNov 12, 2026, 8:23 AM EST
5.63 +0.03 +0.54%
Pre-market · Nov 12, 8:23 AM ET
Day range unavailable
4.97 52-week range 8.16
- YTD
- +2.94%
- 1 year
- +1.82%
News
defenseworld.net Ranger Energy Services (NYSE:RNGR) versus RPC (NYSE:RES) Critical Survey Ranger Energy Services (NYSE: RNGR - Get Free Report) and RPC (NYSE: RES - Get Free Report) are both small-cap energy companies, but which is the superior investment? We will compare the two…
benzinga.com RPC Q3 2026 Earnings Call Transcript RPC (NYSE:RES) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com RPC Q3 Adj. EPS $0.10, Inline, Sales $467.735M Miss $471.400M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 11.11 percent increase over earnings of $0.09 per share from the same period last…
benzinga.com RPC Q2 Adj. EPS $0.08 Beats $0.04 Estimate, Sales $460.869M Miss $469.800M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.04 by 100 percent. This is unchanged from the same period last year. The company reported…
benzinga.com Susquehanna Maintains Neutral on RPC, Lowers Price Target to $6 Susquehanna analyst Charles Minervino maintains RPC (NYSE:RES) with a Neutral and lowers the price target from $7.5 to $6.
benzinga.com Susquehanna Maintains Neutral on RPC, Raises Price Target to $7.5 Susquehanna analyst Charles Minervino maintains RPC (NYSE:RES) with a Neutral and raises the price target from $7 to $7.5.
benzinga.com Susquehanna Maintains Neutral on RPC, Raises Price Target to $7 Susquehanna analyst Charles Minervino maintains RPC (NYSE:RES) with a Neutral and raises the price target from $6 to $7.
benzinga.com RPC Earnings Report: Q4 Overview 
benzinga.com RPC Q4 Earnings Report: What Investors Need to Know 
benzinga.com Earnings Summary: RPC Q4 - benzinga.com Earnings Breakdown: RPC Q4
benzinga.com RPC Q4 Earnings Summary & Key Takeaways 
benzinga.com RPC Q4 Earnings Assessment - benzinga.com RPC: Q4 Earnings Insights
benzinga.com Insights into RPC Q4 Earnings - benzinga.com RPC Earnings Review: Q4 Summary
benzinga.com RPC Q4 Adj. EPS $0.04 Misses $0.06 Estimate, Sales $425.777M Miss $426.464M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.06 by 31.03 percent. This is a 33.33 percent decrease over earnings of $0.06 per share…
benzinga.com Earnings Scheduled For February 3, 2026 
benzinga.com An Overview of RPC's Earnings 
benzinga.com Susquehanna Maintains Neutral on RPC, Raises Price Target to $6 Susquehanna analyst Charles Minervino maintains RPC (NYSE:RES) with a Neutral and raises the price target from $5.5 to $6.- benzinga.com Citigroup Maintains Neutral on RPC, Raises Price Target to $6 Citigroup analyst Scott Gruber maintains RPC (NYSE:RES) with a Neutral and raises the price target from $5.75 to $6.
benzinga.com Earnings Scheduled For October 30, 2025 - benzinga.com RPC Q3 Adj. EPS $0.09 Beats $0.06 Estimate, Sales $447.103M Beat $403.361M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.06 by 60.71 percent. This is unchanged from the same period last year. The company…
- benzinga.com A Glimpse Into The Expert Outlook On RPC Through 4 Analysts
benzinga.com Piper Sandler Maintains Underweight on RPC, Lowers Price Target to $4 Piper Sandler analyst Derek Podhaizer maintains RPC (NYSE:RES) with a Underweight and lowers the price target from $5 to $4.- benzinga.com Susquehanna Maintains Neutral on RPC, Lowers Price Target to $5 Susquehanna analyst Charles Minervino maintains RPC (NYSE:RES) with a Neutral and lowers the price target from $5.5 to $5.
- benzinga.com RPC Q2 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $420.809M Miss $421.075M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.09 by 13.04 percent. This is a 46.67 percent decrease over earnings of $0.15 per share…
- benzinga.com Earnings Scheduled For July 24, 2025
benzinga.com Preview: RPC's Earnings - benzinga.com Stifel Maintains Hold on RPC, Lowers Price Target to $5 Stifel analyst Stephen Gengaro maintains RPC (NYSE:RES) with a Hold and lowers the price target from $6 to $5.
- benzinga.com Piper Sandler Initiates Coverage On RPC with Underweight Rating, Announces Price Target of $5 Piper Sandler analyst Derek Podhaizer initiates coverage on RPC (NYSE:RES) with a Underweight rating and announces Price Target of $5.
- benzinga.com RPC Q1 EPS $0.06, Inline, Sales $332.88M Beat $324.29M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 53.85 percent decrease over earnings of $0.13 per share from the same period last…
- benzinga.com Earnings Scheduled For April 24, 2025
- benzinga.com Susquehanna Maintains Neutral on RPC, Lowers Price Target to $5.5 Susquehanna analyst Charles Minervino maintains RPC (NYSE:RES) with a Neutral and lowers the price target from $6 to $5.5.
- benzinga.com Citigroup Upgrades RPC to Neutral, Lowers Price Target to $4.75 Citigroup analyst Scott Gruber upgrades RPC (NYSE:RES) from Sell to Neutral and lowers the price target from $5.5 to $4.75.
- benzinga.com RPC Reveals Acquisition Of Pintail Alternative Energy, Which Does Business Under Name Pintail Completions, For $245M Pintail is headquartered in Midland, Texas and is a provider of oilfield wireline services in the Permian basin.Acquisition is expected to be accretive to RPC's 2025 earnings per share and operating…
- benzinga.com Citigroup Maintains Sell on RPC, Raises Price Target to $5.5 Citigroup analyst Scott Gruber maintains RPC (NYSE:RES) with a Sell and raises the price target from $5.25 to $5.5.
- benzinga.com RPC Q4 2024 Adj. EPS $0.06, Inline, Sales $335.361M Beat $323.976M Estimate RPC (NYSE:RES) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 68.42 percent decrease over earnings of $0.19 per share from the same period last…
- benzinga.com Earnings Scheduled For January 30, 2025
- benzinga.com Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- benzinga.com IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
- benzinga.com Earnings Scheduled For January 25, 2024 Companies Reporting Before The Bell • Nokia (NYSE:NOK) is projected to report quarterly earnings at $0.15 per share on revenue of $7.05 billion.
- benzinga.com Top 5 Energy Stocks That Could Blast Off This Quarter The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
- benzinga.com Earnings Scheduled For October 25, 2023 Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.
- benzinga.com Earnings Scheduled For July 26, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is estimated to report quarterly earnings at $0.87 per share on revenue of $8.97 billion. • Stellantis (NYSE:STLA) is likely to report earnings…
- benzinga.com Earnings Scheduled For April 26, 2023 Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion.
- benzinga.com 5 Value Stocks In The Energy Sector
- benzinga.com Earnings Scheduled For January 25, 2023 Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion.
- benzinga.com Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product…
- benzinga.com Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At…